Intellia Therapeutics News - June 15, 2026
🟢 Intellia Therapeutics Inc makes sharp 14.8% jump
NTLA is trading at $13.90, up 14.8% versus the comparison close of $12.11 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Intellia Therapeutics Inc is trading 10.2% up today after positive Phase 3 HAELO trial results for HAE therapy
Intellia Therapeutics Inc is trading 10.2% up at $13.35 after releasing additional positive Phase 3 HAELO trial results for its hereditary angioedema...
Intellia Reports Positive Phase 3 Trial Results for HAE Therapy Lonvo-z
Intellia Therapeutics announced additional positive results from its global Phase 3 HAELO clinical trial for lonvoguran ziclumeran (lonvo-z), a single-dose...
🟢 Intellia Therapeutics Inc is trading 5% up today after positive Phase 3 HAELO trial results for lonvo-z
Intellia Therapeutics Inc is trading 5% up at $12.72 in pre-market, rebounding after recent weakness following the disclosure of positive clinical data. • The...